Lincomycin hydrochloride Introduction
Lincomycin hydrochloride is a semi-synthetic chlorinated derivative of lincomycin and is indicated for the treatment of various infectious diseases caused by gram-positive and anaerobic bacteria and also for the treatment of infections caused by methicillin-resistant Staphylococcus aureus.
Application:
1. Oral formulations is suitable for treating respiratory infections, abdominal infection, female reproductive tract infections, pelvic infections, skin and soft tissue infections caused by sensitive Staphylococcus aureus and Streptococcus pneumoniae.
2. In addition to the treatment of the above infections, injected formulations are suitable for treatment of severe infections caused by streptococcus, pneumococcus and staphylococcus such as the surgical adjuvant therapy of septicemia, bone and joint infections, chronic bone and joint infections and Staphylococcus-induced acute hematogenous osteomyelitis.
3. Lincomycin hydrochloride may also be used for the treatment of infectious diseases in patients allergic to penicillin or not suitable for administration of penicillin-type drugs.
| Product name | Lincomycin hydrochloride API |
| Appearance | Off-white crystalline powder |
| CAS | 859-18-7 |
| EINECS | 212-726-7 |
| Assay | Not less than 790ug/mg Lincomycin, tested according to USP43 |
| Shelf Life | 36 months when properly stored |
| Storage | Keep in a cool, dry, dark location |
Complaint
